E-LIB Suche - Ergebnisse für: Kiedrowski, Lesli A - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Jahr

Sortierung: Relevanz

1

Supplementary Table S4 from The Clinical Implications of Re..:

Timothy J. Brown ; Arielle Yablonovitch ; Jacob E. Till...
doi:10.1158/1078-0432.24825864.v1. , 2023

Link: https://doi.org/10.1158/..

2

TRK inhibitor in a patient with metastatic triple-negative ..:

Medford, Arielle J ; Oshry, Lauren ; Boyraz, Baris...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893401/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Supplementary Figure S1 from The Clinical Implications of R..:

Timothy J. Brown ; Arielle Yablonovitch ; Jacob E. Till...
doi:10.1158/1078-0432.24825879.v1. , 2023

Link: https://doi.org/10.1158/..

4

Supplementary Table S2 from The Clinical Implications of Re..:

Timothy J. Brown ; Arielle Yablonovitch ; Jacob E. Till...
doi:10.1158/1078-0432.24825870.v1. , 2023

Link: https://doi.org/10.1158/..

5

Efficacy and Tolerability of ALK/MET Combinations in Patien..:

Ibiayi Dagogo-Jack, MD ; Lesli A. Kiedrowski, MS, MPH ; Rebecca S. Heist, MD, MPH...
http://www.sciencedirect.com/science/article/pii/S2666364323000735. , 2023

Link: https://doi.org/10.1016/..

6

Supplementary Table S3 from The Clinical Implications of Re..:

Timothy J. Brown ; Arielle Yablonovitch ; Jacob E. Till...
doi:10.1158/1078-0432.24825867.v1. , 2023

Link: https://doi.org/10.1158/..

7

Supplementary Table S1 from The Clinical Implications of Re..:

Timothy J. Brown ; Arielle Yablonovitch ; Jacob E. Till...
doi:10.1158/1078-0432.24825876.v1. , 2023

Link: https://doi.org/10.1158/..

8

Efficacy and Tolerability of ALK/MET Combinations in Patien..:

Dagogo-Jack, Ibiayi ; Kiedrowski, Lesli A ; Heist, Rebecca S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391652/. , 2023

Link: http://www.ncbi.nlm.nih...

9

TRK inhibitor in a patient with metastatic triple-negative ..:

Arielle J. Medford ; Lauren Oshry ; Baris Boyraz...
https://doi.org/10.1177/17588359231152844. , 2023

Link: https://doi.org/10.1177/..

10

33 Blood-based tumor mutation burden (bTMB) predicts respon..:

Nicole Zhang ; Leylah Drusbosky ; Jiemin Liao...
https://doaj.org/toc/2051-1426. , 2023

Link: https://doi.org/10.1136/..

11

Prevalence of ARID1A Mutations in Cell-Free Circulating Tum..:

Kurzrock, Razelle ; Aggarwal, Charu ; Weipert, Caroline...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454642/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Prevalence of ARID1A Mutations in Cell-Free Circulating Tum..:

Razelle Kurzrock ; Charu Aggarwal ; Caroline Weipert...
https://www.mdpi.com/2072-6694/14/17/4281. , 2022

Link: https://doi.org/10.3390/..

13

DataSheet_1_Genomic landscape of advanced prostate cancer p..:

Umang Swami ; Raquel Mae Zimmerman ; Roberto H. Nussenzveig...
doi:10.3389/fonc.2022.966534.s001. , 2022

Link: https://doi.org/10.3389/..

14

Genomic landscape of advanced prostate cancer patients with..:

Umang Swami ; Raquel Mae Zimmerman ; Roberto H. Nussenzveig...
https://www.frontiersin.org/articles/10.3389/fonc.2022.966534/full. , 2022

Link: https://doi.org/10.3389/..

15

The economic value of liquid biopsy for genomic profiling i..:

Doreen A. Ezeife ; Eldon Spackman ; Rosalyn A. Juergens...
https://doi.org/10.1177/17588359221112696. , 2022

Link: https://doi.org/10.1177/..

1-15